FDA approval for Mounjaro cardiovascular risk reduction in type 2 diabetes
Eli Lilly’s Mounjaro has received FDA approval to cut cardiovascular risk in type 2 diabetes.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.